跳至主要内容
临床试验/CTRI/2022/03/041190
CTRI/2022/03/041190尚未招募2 期

Efficacy of Habb-e-Mubarak, Habb-e-Hindi Zeeqi and Montelukast in Zeeq-un-nafas â?? A Randomized Open Labelled Controlled Clinical trial

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Known cases of mild to moderate Asthma
  • All gender
  • Age between 21 to 60 years
  • Non-smoker

排除标准

  • Known cases of Acute or severe Asthma (FEV1 <60%)
  • (1) FEV1 < 60% of predicted in spirometry;
  • (2) PEF variability <40% to >30% to at least 2 times during an 1-week
  • monitoring period;
  • (3) use of short-acting bronchodilating medication at least four
  • times daily; and/or
  • (4) Daily use of oral steroid
  • Subject with a History of COPD, Pneumonia, Occupational lung diseases
  • and pulmonary tuberculosis
  • History of Smoking
  • Pregnant & lactating mothers

研究者

发起方
ational Institute of Unani Medicine

相似试验